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Central Message
104
The vasoactive-ventilation-renal score is a novel measure that robustly predicts outcome 105 after surgery for congenital heart disease. 
277
Using each of these individual measurements, we then calculated the VVR at the time of 
287
The primary outcome of interest was hospital length of stay (LOS). We opted to focus 288 the study on hospital LOS because we deemed criteria for hospital discharge as 
298
values for VVR at the study time points were compared using the method of DeLong, 
309
All statistical analyses were performed using STATA version 13 and SAS version 9.4. to the dynamic processes that occur after cessation of cardiopulmonary bypass and M A N U S C R I P T 
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Further validation in a multi-center data set should, however, be performed before 412 widespread application is recommended. 
427
There are some limitations that must be noted. These data come from a single center,
428
which limits their generalizability. The initial work on the VVR was however completed at 
438
were excluded due to ECMO support would be characterized as having prolonged LOS.
439
Also, no patients in our cohort required peritoneal dialysis or continuous renal 
447
Conclusions
448
We have further validated the utility of the VVR score after surgery for congenital heart 449 disease. The VVR calculated at 12 hours postoperatively could be a valuable and 547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568 M A N U S C R I P T Tables   Table 1: M A N U S C R I P T 
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